Companies Veracyte, Inc
Veracyte (VCEA): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Veracyte, Inc’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $7,421,877FY2025
CEO total pay was $7,421,877 in fiscal 2025; the brief holds no earlier figure for this CEO.
FY2025: salary $700,000 · bonus $0 · stock awards $5,890,877 · option awards $0
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Marc Stapley | $700,000 | $0 | $5,890,877 | $0 | $826,000 | $0 | $5,000 | $7,421,877 |
| Chief Executive Officer | ||||||||
| John Leite | 510,300 | 0 | 2,356,325 | 0 | 331,185 | 0 | 5,000 | 3,202,810 |
| Global Chief Commercial Officer | ||||||||
| Rebecca Chambers | 550,000 | 0 | 1,963,604 | 0 | 356,950 | 0 | 5,000 | 2,875,554 |
| Chief Financial Officer | ||||||||
| Annie McGuire | 500,000 | 0 | 1,963,604 | 0 | 324,500 | 0 | 5,000 | 2,793,104 |
| General Counsel and Head of Market Access | ||||||||
| Phillip Febbo | 561,000 | 0 | 1,570,883 | 0 | 364,089 | 0 | 5,000 | 2,500,972 |
| Chief Scientific Officer and Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Marc Stapley | $7,421,877 | — | — | — |
| John Leite | 3,202,810 | — | — | — |
| Rebecca Chambers | 2,875,554 | — | — | — |
| Annie McGuire | 2,793,104 | — | — | — |
| Phillip Febbo | 2,500,972 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Rebecca Chambers | RSU | 1,296 | — | $54,562 |
| Annie McGuire | RSU | 1,429 | — | 60,161 |
| Annie McGuire | Option | 1,758 | 27.8 | — |
| Rebecca Chambers | Option | 2,361 | 26.02 | — |
| Marc Stapley | RSU | 3,534 | — | 148,781 |
| John Leite | RSU | 4,819 | — | 202,880 |
| John Leite | RSU | 4,928 | — | 207,469 |
| Marc Stapley | Option | 6,440 | 26.02 | — |
| John Leite | Option | 7,897 | 23.73 | — |
| John Leite | Option | 8,071 | 19.81 | — |
| Annie McGuire | Option | 12,082 | 23.73 | — |
| Rebecca Chambers | Option | 13,424 | 23.73 | — |
| John Leite | RSU | 17,221 | — | 725,004 |
| Phillip Febbo | PSU | 17,957 | — | 755,990 |
| John Leite | PSU | 22,446 | — | 944,977 |
| Annie McGuire | PSU | 22,446 | — | 944,977 |
| Rebecca Chambers | PSU | 22,650 | — | 953,565 |
| Phillip Febbo | RSU | 24,160 | — | 1,017,136 |
| Phillip Febbo | PSU | 24,160 | — | 1,017,136 |
| Rebecca Chambers | PSU | 26,936 | — | 1,134,006 |
| Annie McGuire | RSU | 28,388 | — | 1,195,135 |
| Rebecca Chambers | RSU | 30,200 | — | 1,271,420 |
| Annie McGuire | RSU | 30,200 | — | 1,271,420 |
| Annie McGuire | PSU | 30,200 | — | 1,271,420 |
| Rebecca Chambers | RSU | 31,541 | — | 1,327,876 |
| John Leite | RSU | 36,240 | — | 1,525,704 |
| John Leite | PSU | 36,240 | — | 1,525,704 |
| Phillip Febbo | Option | 39,352 | 21.96 | — |
| Marc Stapley | Option | 40,272 | 23.73 | — |
| Phillip Febbo | RSU | 46,388 | — | 1,952,935 |
| Marc Stapley | PSU | 51,626 | — | 2,173,455 |
| John Leite | RSU | 57,985 | — | 2,441,169 |
| Annie McGuire | RSU | 57,985 | — | 2,441,169 |
| Rebecca Chambers | RSU | 69,581 | — | 2,929,360 |
| Phillip Febbo | RSU | 74,455 | — | 3,134,556 |
| Marc Stapley | RSU | 90,601 | — | 3,814,302 |
| Marc Stapley | PSU | 90,601 | — | 3,814,302 |
| Marc Stapley | RSU | 94,628 | — | 3,983,839 |
| Marc Stapley | RSU | 133,368 | — | 5,614,793 |
Director compensation
No director compensation table is on file for fiscal year 2025.
Board fee structure and ownership guideline
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $250,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | Robust stock ownership guidelines for directors and executives |
Peer group, and who names Veracyte as a peer
Companies that benchmark against VCEA
No companies currently name VCEA as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Veracyte, Inc | 2025 | Marc Stapley | $700,000 | $5,890,877 | $0 | $826,000 | $7,421,877 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
CEO pay ratio
| Ratio (CEO : median employee) | 38 : 1 |
|---|---|
| CEO total compensation | $7,421,877 |
| Median employee compensation | $196,646 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (7 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Marc Stapley. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · page 59. As printed: 7,421,877. View filing ↗
- Section 01, John Leite. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · page 59. As printed: 3,202,810. View filing ↗
- Section 01, Rebecca Chambers. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · page 59. As printed: 2,875,554. View filing ↗
- Section 01, Annie McGuire. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · page 59. As printed: 2,793,104. View filing ↗
- Section 01, Phillip Febbo. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · page 59. As printed: 2,500,972. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-22. Section “CEO Pay Ratio”. As printed: 38 : 1. View filing ↗
- Veracyte, Inc (subject), Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Veracyte, Inc's own proxy. As printed: 7,421,877. View filing ↗